| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 9,2 M € | +7.3% | 8,6 M € | +12.3% | 7,6 M € | +56.8% | 4,9 M € | +8.7% | 4,5 M € | +21.0% | 3,7 M € | — | — | — | — | — | 276,9 k € | +1554.2% | 16,7 k € | |||||||||
| Gross margin | 5,5 M € | -5.5% | 5,9 M € | — | — | 3,5 M € | +112.1% | 1,6 M € | +9.2% | 1,5 M € | +34.3% | 1,1 M € | -33.1% | 1,7 M € | +62.4% | 1,0 M € | -4.6% | 1,1 M € | +93.5% | 553,0 k € | +170.6% | 204,3 k € | +1962.9% | 9,9 k € | +128.0% | -35,3 k € | ||||
| EBITDA | 2,9 M € | -9.1% | 3,2 M € | +37.5% | 2,4 M € | +2.4% | 2,3 M € | +14.0% | 2,0 M € | +379.3% | 420,9 k € | -7.4% | 454,5 k € | +83.6% | 247,6 k € | -72.7% | 906,0 k € | +92.8% | 470,0 k € | -33.8% | 710,3 k € | +115.5% | 329,6 k € | +115.1% | 153,2 k € | +671.1% | -26,8 k € | +41.9% | -46,2 k € | |
| Operating profit | 2,9 M € | -9.1% | 3,2 M € | +38.6% | 2,3 M € | +3.1% | 2,2 M € | +14.1% | 2,0 M € | +397.8% | 394,4 k € | +12.0% | 352,1 k € | +3478.2% | 9,8 k € | -98.6% | 703,2 k € | +1655.4% | 40,1 k € | -92.6% | 540,2 k € | +148.2% | 217,6 k € | +189.4% | 75,2 k € | +190.9% | -82,7 k € | -43.1% | -57,8 k € | |
| Profit/loss | 2,2 M € | +46.8% | 1,5 M € | -14.8% | 1,8 M € | +17.3% | 1,5 M € | +3.7% | 1,4 M € | +443.6% | 265,0 k € | +34.4% | 197,3 k € | +909.5% | -24,4 k € | -105.9% | 416,2 k € | +4336.2% | -9,8 k € | -102.9% | 339,8 k € | +558.2% | 51,6 k € | -17.1% | 62,2 k € | +167.5% | -92,2 k € | -58.0% | -58,4 k € | |
| Equity | 1,4 M € | +16.5% | 1,2 M € | -30.3% | 1,7 M € | -12.9% | 1,9 M € | -20.9% | 2,4 M € | +146.2% | 985,6 k € | +36.8% | 720,6 k € | +37.7% | 523,3 k € | -4.4% | 547,7 k € | +316.6% | 131,5 k € | -7.0% | 141,3 k € | +148.3% | 56,9 k € | +976.1% | 5,3 k € | +104.0% | -132,0 k € | -231.9% | -39,8 k € | |
| Total assets | 6,5 M € | +11.2% | 5,8 M € | -15.6% | 6,9 M € | -2.6% | 7,1 M € | +14.7% | 6,2 M € | +55.9% | 4,0 M € | +0.3% | 4,0 M € | +6.1% | 3,7 M € | -1.4% | 3,8 M € | +173.8% | 1,4 M € | +10.9% | 1,2 M € | +34.7% | 925,5 k € | +158.6% | 358,0 k € | +50.9% | 237,2 k € | +408.4% | 46,7 k € | |
| Cash | 1,1 M € | -67.2% | 3,3 M € | +10.7% | 3,0 M € | +50.4% | 2,0 M € | +28.4% | 1,6 M € | +281.5% | 410,9 k € | +424.5% | 78,3 k € | -50.4% | 158,0 k € | -65.4% | 456,3 k € | +198.3% | 153,0 k € | -19.9% | 191,0 k € | -5.2% | 201,5 k € | +496.2% | 33,8 k € | +24934.1% | 135,0 € | — | ||
| Debts | 4,9 M € | +6.6% | 4,6 M € | -9.1% | 5,0 M € | +5.8% | 4,7 M € | +42.2% | 3,3 M € | +35.4% | 2,5 M € | -20.4% | 3,1 M € | +1.0% | 3,1 M € | +7.8% | 2,8 M € | +179.0% | 1,0 M € | +16.0% | 877,5 k € | +135.1% | 373,3 k € | +5.8% | 352,7 k € | -4.5% | 369,1 k € | +644.6% | 49,6 k € | |
| Staff | 24,1 | 23,3 | 25,2 | 19 | 19,1 | 16,3 | 14,7 | 11,7 | 10 | 7,5 | 5,5 | 4,1 | 1,6 | 1 | 0,3 | |||||||||||||||
Public limited company · Zaventem · incorporated on 09/04/2010 · 24,1 ETP
Public limited company profitable but thinly capitalised. Cash position declining (-67.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (1,4 M €) relative to earnings. The abridged model hides revenue.
| Unit no. | Name | Location |
|---|---|---|
| 2221860422 | REDPHARMA | Da Vincilaan 7, 1930 Zaventem |
| 2257771406 | RED PHARMA | Rue Coquiamont (MER) 11, 4280 Hannut |
REDPHARMA is a Public limited company incorporated in 2010. Its main activity is: Régie publicitaire de médias. Its registered office is in Zaventem. It employs on average 24,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette